Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.06 is 107% above its 3-year average of -0.90, near the high end of its 3-year range (-1.30–0.06).
111.21% above its 12-month average of -0.54.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.09.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:42:39.900Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.06
EARNINGS PER SHARE (EPS) AVG TTM
-0.54
EARNINGS PER SHARE (EPS) AVG 3Y
-0.90
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+111.21%
CURRENT VS 3Y AVG
+106.70%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.22B
Earnings Per Share (EPS)
0.18
TTM Avg
0.04
3Y Avg
-0.14
5Y Avg
-0.31
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.02
TTM Avg
-0.12
3Y Avg
-0.17
5Y Avg
-0.18
Market Cap
$1.21B
Earnings Per Share (EPS)
-0.14
TTM Avg
0.06
3Y Avg
-0.09
5Y Avg
-0.17
Market Cap
$1.20B
Earnings Per Share (EPS)
-2.40
TTM Avg
-1.76
3Y Avg
-1.59
5Y Avg
-1.20
Market Cap
$1.20B
Earnings Per Share (EPS)
-1.35
TTM Avg
-1.65
3Y Avg
-1.88
5Y Avg
-2.16
Market Cap
$1.27B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.20
3Y Avg
-3.20
5Y Avg
-3.20
Market Cap
$1.18B
Earnings Per Share (EPS)
-124.78
TTM Avg
-85.76
3Y Avg
-67.06
5Y Avg
-58.99
Market Cap
$1.14B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omada Health (OMDA) | $1.22B | 0.06 | -0.54 | -0.90 | N/A |
| Cronos Group Inc. (CRON)vs › | $1.22B | 0.18 | 0.04 | -0.14 | -0.31 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.02 | -0.12 | -0.17 | -0.18 |
| MannKind Corporation (MNKD)vs › | $1.21B | -0.14 | 0.06 | -0.09 | -0.17 |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.20B | -2.40 | -1.76 | -1.59 | -1.20 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.20B | -1.35 | -1.65 | -1.88 | -2.16 |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | -3.20 | -3.20 | -3.20 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.18B | -124.78 | -85.76 | -67.06 | -58.99 |
| Nektar Therapeutics (NKTR)vs › | $1.14B | N/A | -9.21 | -17.43 | -24.99 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 1.69 | 2.70 | 2.53 | 1.91 |
Trailing EPS (TTM)
$0.06
Forward EPS (Est.)
$0.33
P/E Ratio
326.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.22 |
| 2024-12-31 | -0.85 |
| 2023-12-31 | -1.21 |
| 2022-12-31 | -1.30 |
